Effect of Zingiber officinale on Lipid Profile and Some Inflammatory Markers in Diabetic Hemodialysis Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Table 1

Baseline characteristics of the patients in intervention and control groups.

Variables	Ginger group (n = 22)	Placebo group (n = 22)	value
Age (years)	60.05 ± 11.12	59.64 ± 10.69	0.902
Sex			0.763^†
Men (%)	11 (50%)	12 (54.5%)
Women (%)	11 (50%)	10 (45.5%)
Height [28]	161.46 ± 8.70	161.76 ± 9.62	0.916
Weight [12]	69.67 ± 10.76	74.55 ± 14.31	0.209
BMI (kg·m^−2)	26.48 ± 3.71	28.41 ± 4.35	0.123
Dialysis frequency			0.709^†
Two sessions per week	4 (18.2%)	5 (22.7%)
Three sessions per week	18 (81.8%)	17 (77.3%)
Drug history
Antilipids	6 (27.3%)	7 (31.8%)	0.741^†

Values are reported as mean ± SD or median (IQR) for quantitative data and frequency (percentage) for qualitative data. Independent T-test, ^#Mann–Whitney U test, ^†chi-square test.